[
  {
    "ts": null,
    "headline": "Medtronic (MDT) Stock Declines While Market Improves: Some Information for Investors",
    "summary": "Medtronic (MDT) closed the most recent trading day at $84.25, moving -1.01% from the previous trading session.",
    "url": "https://finnhub.io/api/news?id=76343e1d047b0d63077f2bb1dabed6474d974abe9a1cee536e93325462c3ceb5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747259113,
      "headline": "Medtronic (MDT) Stock Declines While Market Improves: Some Information for Investors",
      "id": 134461079,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic (MDT) closed the most recent trading day at $84.25, moving -1.01% from the previous trading session.",
      "url": "https://finnhub.io/api/news?id=76343e1d047b0d63077f2bb1dabed6474d974abe9a1cee536e93325462c3ceb5"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic PLC stock outperforms competitors despite losses on the day",
    "summary": "Medtronic PLC stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=32c1d820bc25a7a2e59fbfb8ba92bc575c64273cc1eb563b85191f2b6121c4e8",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747240620,
      "headline": "Medtronic PLC stock outperforms competitors despite losses on the day",
      "id": 134471357,
      "image": "",
      "related": "MDT",
      "source": "MarketWatch",
      "summary": "Medtronic PLC stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=32c1d820bc25a7a2e59fbfb8ba92bc575c64273cc1eb563b85191f2b6121c4e8"
    }
  },
  {
    "ts": null,
    "headline": "BlackRock Equity Dividend Fund Q1 2025 Commentary",
    "summary": "BlackRock Equity Dividend Fund posted returns of 4.53% (Institutional shares) and 4.45% (Investor A shares, without sales charge) for the first quarter of 2025.",
    "url": "https://finnhub.io/api/news?id=f9a980c584a4260c81970eb03e2b8a8d507219173dcc8818fdfa3dbdfbe01a4d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747237740,
      "headline": "BlackRock Equity Dividend Fund Q1 2025 Commentary",
      "id": 134452994,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2182036952/image_2182036952.jpg?io=getty-c-w1536",
      "related": "MDT",
      "source": "SeekingAlpha",
      "summary": "BlackRock Equity Dividend Fund posted returns of 4.53% (Institutional shares) and 4.45% (Investor A shares, without sales charge) for the first quarter of 2025.",
      "url": "https://finnhub.io/api/news?id=f9a980c584a4260c81970eb03e2b8a8d507219173dcc8818fdfa3dbdfbe01a4d"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic: Quite A Few Supportive Sub-Plots Ahead Of The Q4-25 Earnings",
    "summary": "Medtronic has outperformed the S&P500 and other healthcare stocks from the S&P500 this year. Read my MDT earnings preview.",
    "url": "https://finnhub.io/api/news?id=63061610f51ac5225dc2863f751f54211dc25516d472610217c2aaf77b0b6c38",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747216456,
      "headline": "Medtronic: Quite A Few Supportive Sub-Plots Ahead Of The Q4-25 Earnings",
      "id": 134436141,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1134382852/image_1134382852.jpg?io=getty-c-w1536",
      "related": "MDT",
      "source": "SeekingAlpha",
      "summary": "Medtronic has outperformed the S&P500 and other healthcare stocks from the S&P500 this year. Read my MDT earnings preview.",
      "url": "https://finnhub.io/api/news?id=63061610f51ac5225dc2863f751f54211dc25516d472610217c2aaf77b0b6c38"
    }
  },
  {
    "ts": null,
    "headline": "Orchestra BioMed Holdings - Breakthrough Device Designation Gives Speculative Optimism",
    "summary": "Orchestra BioMed's AVIM earns FDA breakthrough designation, sparking investor optimism. Click here to read why OBIO stock is a Hold.",
    "url": "https://finnhub.io/api/news?id=c42447832a3f698041a68f715b1716f5e74de12df0c68039b33c619c6dfa33b1",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747183531,
      "headline": "Orchestra BioMed Holdings - Breakthrough Device Designation Gives Speculative Optimism",
      "id": 134431615,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2148525995/image_2148525995.jpg?io=getty-c-w1536",
      "related": "MDT",
      "source": "SeekingAlpha",
      "summary": "Orchestra BioMed's AVIM earns FDA breakthrough designation, sparking investor optimism. Click here to read why OBIO stock is a Hold.",
      "url": "https://finnhub.io/api/news?id=c42447832a3f698041a68f715b1716f5e74de12df0c68039b33c619c6dfa33b1"
    }
  }
]